Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor systems participating in nicotine-specific effects

I Sziráki1, H Sershen, M Benuck

  • 1Center for Neurochemistry, The Nathan S. Kline Institute, Orangeburg, NY10962, USA.

Neurochemistry International
|January 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASSOCIATION BETWEEN GALECTIN-3 AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES MELLITUS: A COMPARATIVE STUDY.

Georgian medical news·2026
Same author

Disposable paper electrodes for detection of changes in dopamine concentrations in rat brain homogenates.

Talanta·2024
Same author

Biometric Identification System as a Potential Source of Nosocomial Infection Among Medical Students.

Journal of microscopy and ultrastructure·2022
Same author

Axion Dark Matter Experiment: Detailed design and operations.

The Review of scientific instruments·2022
Same author

Loss of Neutrophil Homing to the Periodontal Tissues Modulates the Composition and Disease Potential of the Oral Microbiota.

Infection and immunity·2021
Same author

Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis.

The International journal on drug policy·2021

Nicotine and cocaine impact dopamine levels in the brain differently, involving distinct receptor systems. However, both drug effects on dopamine in the nucleus accumbens are partially mediated by dopamine D1 receptors.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Addiction Research

Background:

  • Drug self-administration is traditionally linked to dopamine release in the nucleus accumbens.
  • Emerging evidence suggests other factors, like stress, also elevate dopamine, indicating a more complex reward system.
  • This complexity may involve different reward pathways for various psychoactive compounds.

Purpose of the Study:

  • To compare the receptor mechanisms underlying dopamine increases in the nucleus accumbens induced by nicotine versus cocaine.
  • To investigate the roles of specific receptor antagonists in modulating these dopamine level changes.
  • To elucidate potential interactions between nicotine and cocaine on dopamine release.

Main Methods:

  • Conscious rats were administered nicotine and cocaine intravenously, alone or in combination.

Related Experiment Videos

  • Dopamine level changes in the nucleus accumbens were measured using in vivo microdialysis.
  • The effects of receptor-specific antagonists (nicotinic, muscarinic, NMDA, dopamine D1) were assessed.

    • Main Results:

    • Nicotine and cocaine exhibited additive effects on dopamine levels when administered together, suggesting distinct but summating pathways.
    • Nicotinic, muscarinic, and NMDA receptor antagonists blocked nicotine-induced dopamine release, highlighting multiple receptor involvement.
    • These antagonists did not affect cocaine-induced dopamine release, indicating different receptor dependencies.
    • A dopamine D1 receptor antagonist (SCH-23390) inhibited dopamine increases caused by both nicotine and cocaine.

    Conclusions:

    • Nicotine and cocaine engage partially distinct receptor systems to increase dopamine in the nucleus accumbens.
    • Dopamine D1 receptors play a crucial role in the central effects of both nicotine and cocaine on dopamine release.
    • The findings reveal specific receptor differences and interactions in the neurochemical pathways of these two drugs.